Page 1902 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Index 1329

Acute right heart syndromes, 308–318 Airborne precautions, in intensive-care Alveolar hypoxic vasoconstriction
acute-on-chronic pulmonary unit, 29 (AHV), 314
hypertension, 314 Air embolism, 185, 333–335 Alveolar ventilation, 405
acute pulmonary hypertension, bronchovenous, 1158 Ambulatory extracorporeal membrane
312–314, 312t management of, 334–335 oxygenation (ECMO), 481
acute lung injury/acute respiratory pathophysiology, 333, 333t American Association of Critical
distress syndrome, 313 presentation, 334, 334ft Care Nurses
acute sickle chest syndrome, 313 Airflow obstruction on communication, 116
cardiac surgery and cardiopulmonary dynamic hyperinflation and, 485, 486f on critical care, 116
bypass, 314 measurement of, 498 American Burn Association
right ventricular infarction, 312–313 Air leakage, compensation for, 379 establishment of criteria for burn patients,
sepsis, 313 Airtraq™, 390 1188–1189
ancillary therapies for acute right heart Airway gas conditioning, 379 Practice Guidelines for Burn Shock
syndromes, 317 Airway management, 384–396 Resuscitation, 1186
establishing effective circulating volumes, assessing patient prior to intubation, American Hospital Association, 57
314–315 385–386, 385t, 386t American Medical Informatics
maximizing myocardial function, in burn patients, 1181, 1181f Association, 49
optimize coronary sinus complications, 393–394, 393t American Recovery and Re-investment
perfusion, 315–316 equipment, 387, 387t Act (2007), 49
pathophysiology of, 309–312, 309f, 310t, indications for intubation, 385, 385t American Society for Healthcare
311f, 312ft muscle relaxants and, in intensive-care Engineering, 57
reducing right ventricle afterload and unit, 388 American Society of Anesthesiologists’
right ventricle (RV) ischemia, pharmacologic preparation and use, Difficult Airway Algorithm, 390
316–317 387–388, 387t American Spinal Injury Association (ASIA),
right ventricular physiology, 309 physiologic changes associated with scoring system of, 1138, 1139f
treatment of, 314, 314t intubation and mechanical American Telemedicine Association, 52
Acute sickle chest syndrome, 313 ventilation, 393 Amikacin, 547
Acute thrombotic arterial occlusion, 1039 procedures for intubation, 388–393 Aminoglycosides, 547, 549t
Acute tubular necrosis, 919–920 changing endotracheal tube, nephrotoxicity and, 920–922, 920t
Acute tubulointerstitial nephritis, 922 392–393 Aminophylline, 500
Acute variceal hemorrhage, difficult airway, 390, 392, 392f Amiodarone-induced thyrotoxicosis,
fiberoptic, 389–390, 390f
994–995, 995t
1030–1031 https://kat.cr/user/tahir99/
Acute ventricular dysfunction, 231f, intubating with laryngeal mask airway, thyroid disease and, 994–995, 995t
232–233 390, 392f Amnesia, Korsakoff-like, 669
ADAMTS13, 852, 859 nasotracheal, 389 Amniotic fluid embolism in pregnancy, 1266
Adaptive support ventilation, orotracheal, 388–389 Amoxicillin-clavulanic acid, 699
436–437 teaching skills in, 395, 396t Amphetamines, 1210
Adenoviridae, 674 in tetanus, 732 Amphotericin B, 651
Adjunctive corticosteroids, 634 tracheostomy, 394–395 Amphotericin B lipid (ABLC), 621
Adjunctive testing, for neuromuscular injury, complications of, 395 Ampicillin-sulbactam, 699
766–769, 767f, 768t indications, 394 Amrinone, 316
Adjuvant therapies minitracheostomy, 395 Amur virus, 742
in decompression illness, 1322 percutaneous versus surgical, Anabolic steroids in burn patients, 1188
for malaria, 727 394–395 Anaerobic cellulitis, 691
for primary percutaneous coronary Airway pressure release ventilation (APRV), Analgesia, 146–147
intervention, 300–302, 301t 435–436 epidural, 147
Adrenal insufficiency, 260, 948, 1144 Airways, 250–251, 251t indications for, 145–146
in burn patients, 1187 extrathoracic, 404 neuraxial opiate, 147–148
diagnosis of, 983 Akinetic mutism, 830 regional techniques for, 147–148
Adrenal shock, 238 Albumin, 572 Analgesics, 112–113
Advance care planning, 127 Aldosterone, 1046 sickle cell disease and, 912–913,
Advanced critical care echocardiography, Alemtuzumab, 604 912t, 913t
207–208 Alkalemia, acid-base balance and, Anaphylactic and anaphylactoid reactions,
Advanced Trauma Life Support 969, 970t 1269–1279
(ATLS), 1117 Alkaline tide, 970 causes of anaphylaxis in critical care unit or
Adverse drug reactions, Alkalosis operating room, 1271–1272
1239–1241 metabolic, 932, 973, 973f clinical presentation, 1274, 1274t
Adverse reactions, 1285 respiratory, 497, 951, 974 differential diagnosis of, 1275–1277,
to alternative drugs, 1286 Alkhurma hemorrhagic fever, 738 1275t, 1276t
Afterdepolarization, 278 Allopurinol, 878 epidemiology of, 1270, 1270t
delayed, 278 Alopecia, 1284 etiology, 1271, 1271t
early, 278 Alveolar-capillary barrier, 565 laboratory testings for triggers of
Agency for Healthcare Research and Alveolar-capillary membrane injury and anaphylaxis, 1277, 1277t
Quality (AHRQ) hospital surge disruption, 455 pathophysiology, 1272–1274, 1273ft, 1274f
model, 59 Alveolar hemorrhage, 895 treatment of, 1277–1279, 1277t, 1278t
Aging, sarcopenia of, 108 Alveolar hypoventilation, 515, 1051–1052 Anaphylactic shock, 238, 260

Index.indd 1329 23-01-2015 15:33:50